Dr. Wichelmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22250 Providence Dr
Ste 301A
Southfield, MI 48075Phone+1 248-849-3254Fax+1 248-849-5449
Education & Training
- Nova Southeastern University College of Osteopathic MedicineClass of 2019
Certifications & Licensure
- MI State License 2023 - 2024
- IL State License 2019 - 2023
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 31 citationsBevacizumab and gastrointestinal perforations: a review from the FDA Adverse Event Reporting System (FAERS) database.Thomas A. Wichelmann, Sufyan AbdulMujeeb, Eli D. Ehrenpreis
Alimentary Pharmacology & Therapeutics. 2021-09-09 - 2 citationsA Summary of the Rare Reports of Osteonecrosis of the Jaw Associated With Tumor Necrosis-α Inhibitors in the United States Food and Drug Administration's Adverse Event...Thomas Adam Wichelmann, Hardeep S Ahdi, Sasirekha Pandravada, Eli D Ehrenpreis
Journal of Oral and Maxillofacial Surgery. 2023-10-01 - 13 citationsMedication-induced osteonecrosis of the jaw: a review of cases from the Food and Drug Administration Adverse Event Reporting System (FAERS).Hardeep S Ahdi, Thomas Adam Wichelmann, Sasirekha Pandravada, Eli D Ehrenpreis
BMC Pharmacology & Toxicology. 2023-03-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: